Page 2 - Epicentrx Cy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Epicentrx cy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Epicentrx Cy Today - Breaking & Trending Today

EpicentRx Publishes Phase 2 Results for RRx-001 as an Anti-Mucositis Agent in Patients Receiving Radiation for Head and Neck Cancers

/PRNewswire/ EpicentRx, a leading edge, clinical stage biopharmaceutical company, announced the publication of Phase 2 results of the PREVLAR trial which. ....

United States , University Of Texas , Prnewswire Epicentrx , David Sher , Stephen Sonis , Faculty Of The Dana Farber Cancer Institute , University Of Texas Southwestern , International Journal Of Radiation Oncology , International Journal , Radiation Oncology , Texas Southwestern , Harvard Professor , Oral Medicine , Distinguished Faculty , Dana Farber Cancer Institute ,

EpicentRx Announces Patent Issued for Radiation Protection with RRx-001 in Combination Regimens

/PRNewswire/ EpicentRx Inc. ("EpicentRx"), a leading-edge, clinical stage biopharmaceutical company that uses groundbreaking science to treat cancer and. ....

Tonyr Reid , Trademark Office , Prnewswire Epicentrx Inc , Drug Administration , Animal Efficacy Rule , Acute Radiation Syndrome , Animal Rule , Chief Executive Officer ,

EpicentRx Awarded Funding from FightMND to Evaluate Therapeutic Potential of RRx-001 in Motor Neuron Disease (aka ALS)

/PRNewswire/ EpicentRx Inc. ("EpicentRx"), a late-stage biopharmaceutical company with platforms that treat and target multiple immune-mediated inflammatory. ....

San Diego , United States , Rob Henderson , Epicentrx Cy , Richard Gordon , Tonyr Reid , Pam Mccombe , Translational Research Institute , Queensland University Of Technology , Prnewswire Epicentrx Inc , Centre For Microbiome Research , Michaelj Fox Foundation For Parkinson Research , Associate Professor Richard Gordon , Queensland University , Microbiome Research , Central Nervous System , Royal Brisbane , Professor Pam Mccombe , Chief Executive Officer ,

EpicentRx Announces Presentations Focusing on RRx-001 Inhibition of the NLRP3 Inflammasome at Two Upcoming Scientific Conferences

/PRNewswire/ EpicentRx, a late clinical stage biopharmaceutical company with novel therapies to target cancer and inflammatory diseases, announced it will. ....

United States , San Diego , Prnewswire Epicentrx , Epicentrx Cy , Inflammasome Therapeutics Summit , Control Number , Disease Molecular , Protects Against Inflammasome Driven , Proof Of Concept Trials , Various Disease Groups , Clinical Relevance ,

EpicentRx Announces First Patient Dosed in China for the Phase 3 REPLATINUM Global Study with RRx-001 in Third Line and Beyond Extensive Stage Small Cell Lung Cancer (SCLC)

/PRNewswire/ EpicentRx, a late clinical stage biopharmaceutical company with novel therapies to target cancer and inflammatory diseases, announced today the. ....

Prnewswire Epicentrx , Tonyr Reid , Sciclone Pharmaceuticals , Greater China ,